On the plotter, this manifests as deeper troughs
The 505(b)(2) pathway is appropriate for reformulations (new dosage form, new route of administration, new dosing regimen), new combinations of previously approved drugs, new indications for approved molecules, enantiomers or active metabolites of approved drugs, and new salt or polymorph forms with different biopharmaceutical properties
GLP-1 and OSA GLP-1 and glucose-dependent insulinotropic polypeptide (GIP) are the 2 main incretins described
#DiabetesCare #Pharma #Pharmacology #DiabetesAwareness #Gliptins #MechanismOfAction #Onpharma Onpharma Tales Post Understanding Diabetes Treatment: Mechanism of Action of Gliptins (DPP-4 Inhibitors) Gliptins (Sitagliptin, Vildagliptin, Saxagliptin, Linagliptin) are a widely used class of oral antidiabetic drugs
Peptide source quality can also vary